PD-9 Three-arm phase II/III randomized controlled trial in patients with unresectable/metastatic gall bladder cancer with poor performance status: Erlotinib or capecitabine v/s best supportive care
| Autor: | B. Kataria, A. Sharma, R. Pramanik, R. Sahoo, S. Thulkar, M. Yadav, S. Mishra, C. Prasad, S. Vishnubhatla |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S242 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.04.087 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|